Predictive value of HIV type 1 DNA levels on overall survival in HIV-related lymphoma patients treated with high-dose chemotherapy (HDC) plus autologous stem cell transplantation (ASCT)

AIDS Research and Human Retroviruses

Volumn 26, Issue 2, 2010, Pages 245-251

  Bortolin, Maria Teresa ^a   Zanussi, Stefania ^a   Talamini, Renato ^a   Simonelli, Cecilia ^a   Pratesi, Chiara ^a   Tedeschi, Rosamaria ^a   Abbruzzese, Luciano ^a   Manuele, Rosa ^a   Rupolo, Maurizio ^a   Tirelli, Umberto ^a   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; MEPREDNISONE; OXALIPLATIN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOMA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADULT; ANTINEOPLASTIC AGENTS; DNA, VIRAL; FEMALE; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STEM CELL TRANSPLANTATION; VIRAL LOAD;

EID: 77149144934     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0081     Document Type: Article

References (30)

1. Philip T, Guglielmi C, Hagenbeek A, et al.: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540-1545.
2. Serrano D, Carriòn R, Balsalobre P, et al.: HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 2005;33:487-494.
3. Krishnan A, Molina A, Zaia J, et al.: Durable remission with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005;105:874-878.
4. Gabarre J, Marcelin AG, Azar N, et al.: High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: Results and impact on HIV disease. Haematologica 2004;89: 1100-1108.
5. Re A, Cattaneo C, Michieli M, et al.: High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003;21:4423-4427.
6. Wagner-Johnston ND and Ambinder RF: Blood and marrow transplant for lymphoma patients with HIV/AIDS. Curr Opin Oncol 2008;20:201-205.
7. Mounier N, Spina M, and Gisselbrecht V: Modern management of non-Hodgkin lymphoma in HIV-infected patients. Br J Haematol 2007;136:685-698.
8. Koelsch KK, Liu L, May S, et al.: Dynamics of total, linear non-integrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis 2008;197:411-419.
9. Tierney C, Lathey JL, Christopherson C, et al.: Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. J Infect Dis 2003;187:144-148.
10. Sarmati L, Parisi SG, Nicastri E, et al.: Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens. J Med Virol 2007;79: 880-886.
11. Kostrikis LG, Touloumi G, Karanicolas R, et al.: Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 2002;76:10099-10108.
12. + T cell counts. J Infect Dis 2005;192:46-55.
13. Resino S, Pérez A, Seoane E, et al.: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: Might be better than expected? AIDS Res Hum Retroviruses 2007;23:543-548.
14. Bortolin MT, Simonelli C, Zanussi S, et al.: Effects on virological and immunological parameters during CD34 mobilization in HIV patients with lymphoma. Am J Hematol 2006;81(10):800-802.
15. Viard JP, Burgard M, Hubert JB, et al.: Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 counts and HIV-1 DNA level. AIDS 2004;18(1):45-49.
16. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278(5341):1295-1300.
17. Douek DC, Brenchley JM, Betts MR, et al.: HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417(6884): 95-98.
18. Kabamba-Mukadi B, Henrivaux P, Ruelle J, Delferrière N, Bodéus M, and Goubau P: Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+cells by LightCycler real-time PCR. BMC Infect Dis 2005;5(1):15.
19. Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, and Re MC: Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 2004;29(4):282-289.
20. Gibellini D, Borderi M, De Crignis E, et al.: DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. J Infect 2008; 56(3):219-225.
21. Avettand-Fenoel V, Boufassa F, Galimand J, Meyer L, Rouzioux C, and ANRS SEROCO Cohort Study Group: HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is. J Clin Virol 2008;42(4):399-404.
22. Dalmasso C, Carpentier W, Meyer L, et al.: Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: The ANRS Genome Wide Association 01 study. PLoS ONE 2008;3:e3907.
23. Chun TW, Engel D, Berrey MM, Shea T, Corey L, and Fauci AS: Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 1998;95(15):8869-8873.
24. Valentin A, Rosati M, Patenaude DJ, et al.: Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci USA 2002; 99(10):7015-7020.
25. Chomont N, El-Far M, Ancuta P, et al.: HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009;15:893-900.
26. Laurence J and Astrin SM: Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci USA 1991;88(17):7635-7639.
27. Shiramizu B, Herndier BG, and McGrath MS: Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas. Cancer Res 1994;54(8):2069-2072.
28. Katano H, Sato Y, Hoshino S, et al.: Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient. Microbes Infect 2007;9(14-15):1581-1589.
29. Holland HK, Saral R, Rossi JJ, et al.: Allogenic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 1989;111(12):973-981.
30. Avettand-Fenoel V, Mahlaoui N, Chaiw ML, et al.: Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART. AIDS 2007;21(6):776-777.